维普期刊资源整合服务平台（V6.5）

79篇 您的检索式：作者名="Feagan G"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial显示文摘	Stephen B Hanauer Brian G Feagan Gary R Lichtenstein Lloyd F Mayer S Schreiber Jean Frederic Colombel Daniel Rachmilewitz Douglas C Wolf Allan Olson Weihang Bao Paul Rutgeerts	2002	The Lancet2002，，9317：	6
2	Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trial 显示文摘	Sandborn W J Schreiber S Feagan B G	2011	Clin Gastroenterol Hepatol2011，9，8：	1
3	Infliximab forinduction and maintenance therapy for ulcerative colitis显示文摘	RUTGEERTS P SANDBORN W J FEAGAN B G	2005	NEngl J Med2005，353，23：	1
4	A review of activ ity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis显示文摘	ErHaens G Sandborn WJ Feagan BG	2007	Gastroenterology2007，132，2：	1
5	A review of activi- ty indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis 显示文摘	D'Haens G Sandborn WJ Feagan BG	2007	Gastroenterology2007，132，2：	1
6	Infliximab for induction and maintenance therapy for ulcerative colitis显示文摘	Rutgeerts P Sandborn W J Feagan B G		New England Journal of Medicine0，，：	1
7	Low-Dose Cyclosporine for the Treatment of Crohn's Disease显示文摘	Feagan G John M	1994	Med1994，330，：	1
8	A review of activity indices and effi- cacy end points for clinical trials of medi- cal therapy in adults with ulcerative colitis显示文摘	D Haens G Sandbom WJ Feagan BG	2007	Gastroenterology2007，132，2：	1
9	Safety of infliximab in Crohn's disease:data from the 5000-patients TREAT registry 显示文摘	LICHTENSTEIN G COHEN RD FEAGAN BG	2004	Gastroenterol2004，126，11：	1
10	Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty显示文摘	FEAGAN B G WONG C J KIRKLEY A	2000	Ann Intern Med2000，33，：	1
11	Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial显示文摘	William J Sandborn Daniel H Present Kim L Isaacs Douglas C Wolf Eugene Greenberg Stephen B Hanauer Brian G Feagan Lloyd Mayer Therese Johnson Joseph Galanko Christopher Martin Robert S Sandler	2003	Gastroenterology2003，，2：	1
12	CDP571,a Humanised Monoclonal Antibody to Tumournecrosis Factor,for Moderate to Severe Crohn's Disease:a Randomised,double Blind,Placebo Controlled Trial显示文摘	Sandborn W Feagan G	2004	Gut2004，53，：	1
13	Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin显示文摘	Feagan BG Greenberg GR Wild G		0，，：	1
14	Maintenance therapy for inflammatory bowel disease显示文摘	Brian G Feagan	2003	The American Journal of Gastroenterology2003，，12：	1
15	Certolizumab pegol for the treatment of Crohns disease 显示文摘	SANDBORN W J FEAGAN B G STOINOV S	2007	N Engl J Med2007，357，3：	1
16	Treatment of ulcerative colitis with a humanized antibody to the a4-b7 integrin 显示文摘	Feagan BG Greenberg GR Wild G	2005	N Engl J Med2005，352，24：	1
17	Treatment of ulcerative colitis with a humanized antibody to the a4-b7 integrin显示文摘	Feagan BG Greenberg GR Wild G		0，，24：	1
18	A rev- iew of activity indices and efficacy end points for clinical trims of medical therapy in adults with ulcerative colitis 显示文摘	DHAENS G SANDBORN W J FEAGAN B G	2007	Gastroenterology2007，132，2：	1
19	Mainte- nance infliximab for Crohn's disease:the ACCENT I ran- domised trial 显示文摘	Hanauer S B Feagan B G Lichtenstein G R	2002	Lancet2002，359，9317：	1
20	Treatment of Ulcerative Colitis with a Humanized Antibody to the alpha4beta7 integrin显示文摘	Feagan BG Greenberg GR Wild G	2005	N Engl J Med2005，352，24：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示